期刊文献+

PD-1免疫抑制剂联合化疗患者不良反应的护理 被引量:8

下载PDF
导出
摘要 总结15例PD-1免疫抑制剂联合化疗治疗肿瘤患者护理,针对出现的消化道、发热、肺炎、皮疹、甲状腺及肾上腺皮质功能减退、骨髓抑制不良反应给予相应的饮食指导、皮肤护理、药物治疗及严格采取保护性隔离措施,预防感染,保证治疗顺利进行。
作者 陈宝贵 王蕊
出处 《天津护理》 2018年第6期706-707,共2页 Tianjin Journal of Nursing
  • 相关文献

参考文献1

二级参考文献12

  • 1Kirkwood J M,Butterfield L H,Tarhini A A, et al. Immunotherapy of cancer in 2012[J]. CA Cancer J Clin,2012,62(5) =309-335.
  • 2Breakthrough of the year 2013. Notable developments[J]. Science. 2013,342(6165) : 1435- 1441.
  • 3Lawrence M S,Stojanov P,Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes[J]. Na- ture,2013,499(7457) :214-218.
  • 4Pardoll D M. The blockade of immune checkpoints in cancer immu- notherapy[J]. Nat Rev Cancer,2012,12(4)=252-264.
  • 5Postow M A, Callahan M K, Wolchok J D. Immune Checkpoint Blockade in Cancer Thcrapy[J]. J Clin Oncol, 2015, doi: 10. 1200/ JCO. 2014.59. 4358.
  • 6Kyi C,Postow M A. Checkpoint blocking antibodies in cancer im munotherapy[J]. FEBS Lett,2014,588(2) :368-376.
  • 7Armand P,Nagler A,Weller E A,et al. Disabling immune tolerance by programmed death I blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lym- phoma=results of an international phase II trialEJT. J Clin Oncol, 2013,31(33):4199-4206.
  • 8Freeman-Kdler M,Weber J S. Anti-programmed death receptor 1 immunotherapy in melanoma= rationale, evidence and clinical poten- tial[J]. Ther Adv Med Oncol,2015,7(1) :12-21.
  • 9Robert C, Long G V, Brady B, et al. Nivolumab in Previously Un- treated Melanoma without BRAF Mutation[J]. N Engl J Med, 2015,372(4) :320-330.
  • 10Antonia S J, Larkin J, Ascierto P A. lmmuno-oneology Combina- tions:A Review of Clinical Experience and Future Prospects[J]. Clin Cancer Res, 2014,20(24) : 6258- 6268.

共引文献7

同被引文献53

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部